Cme Group (CME) Gains from Investment Securities: 2009-2025

Historic Gains from Investment Securities for Cme Group (CME) over the last 15 years, with Sep 2025 value amounting to $22.2 million.

  • Cme Group's Gains from Investment Securities rose 86.55% to $22.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $34.5 million, marking a year-over-year increase of 104.14%. This contributed to the annual value of $33.0 million for FY2024, which is 195.93% up from last year.
  • Cme Group's Gains from Investment Securities amounted to $22.2 million in Q3 2025, which was up 3,600.00% from $600,000 recorded in Q2 2025.
  • In the past 5 years, Cme Group's Gains from Investment Securities registered a high of $430.0 million during Q2 2022, and its lowest value of -$451.3 million during Q4 2022.
  • Over the past 3 years, Cme Group's median Gains from Investment Securities value was $5.3 million (recorded in 2024), while the average stood at $2.7 million.
  • As far as peak fluctuations go, Cme Group's Gains from Investment Securities surged by 8,766.67% in 2021, and later tumbled by 90,360.00% in 2022.
  • Cme Group's Gains from Investment Securities (Quarterly) stood at $500,000 in 2021, then tumbled by 90,360.00% to -$451.3 million in 2022, then soared by 97.21% to -$12.6 million in 2023, then spiked by 127.78% to $3.5 million in 2024, then soared by 86.55% to $22.2 million in 2025.
  • Its Gains from Investment Securities was $22.2 million in Q3 2025, compared to $600,000 in Q2 2025 and $8.2 million in Q1 2025.